Kit Com

LoValTech (LVT) was founded 1 year ago to support the ambitious research project of the University of Tours and the National Research Institute for Agriculture, Food and Environment (INRAE)

We are engaged in the industrial development phase of a new generation protein nasal vaccine against Covid-19 available to the world population.

Today, our universal vaccine is the only one in the world capable to :

• Stop the transmission of the virus and
• Protect against variants of the future

In addition, our vaccine can be stored at positive temperature, which makes it usable by the entire world population, in terms of logistics.

Finally, LVT will benefit from its End-to-End Platform to develop innovative vaccines against infectious diseases with high unmet medical need such as Flu, Bronchiolitis or Malaria.

Within one year, we succeeded in performing the preclinical studies and we have completed the GMP vaccine production, to get the clinical batches in time and start the clinical studies Phase I/II in September 2023 (First in human). These studies are already sponsored by ANRS-MIE and will be performed by the CIC of Hôpital Cochin of Paris and CHRU Bretonneau of tours.

In 2022, we have been awarded i-Lab and Tours Métropole Top Entreprises, and selected by the French Tech Rise and Hello Tomorrow.

I would like to take the opportunity to thanks all our partners and supports, my Associates and more globally my Team and the BioMAP Team for the great job done during this past year.

Patrick Barillot,

CEO, LoValTech

MESRI https://www.enseignementsup-recherche.gouv.fr/fr; ANRS-MIE https://www.anrs.fr ; Inserm Transferthttps://www.inserm-transfert.fr; Université de Tours https://www.univ-tours.fr; INRAE https://www.inrae.fr; BPI France https://www.bpifrance.fr; DRARI https://www.enseignementsup-recherche.gouv.fr; INPI https://www.inpi.fr; Devup https://www.devup-centrevaldeloire.fr; Région Centre val de Loire https://www.centre-valdeloire.fr; Guillaume St Cricq https://www.indre-et-loire.gouv.fr; Le Lab’O https://www.le-lab-o.fr; Stéphanie Rist stephanie.rist@assemblee-nationale.fr; ANR https://.www.anr.fr CCI Touraine https://www.touraine.cci.fr; Covireivac https://www.covireivac.fr; CIC Bretonneau https://www.chu-tours.fr; Hôpital Cochin https://www.aphp.fr; Plateforme Primmo https://www.primmo.chr-orléans.fr; GTP Bioways https://www.gtp-bioways.com; Aptar https://www.aptar.com; ZAZ Ventures https://www.zazventures.com; Medspray https://medspray.com; C.Ris Pharma https://www.c-rispharma.com; La French Tech Rise https://lafrenchtech.com/fr/; MabDesign https://www.mabdesign.fr; Euraxi https://www.euraxi.fr; Icosa https://www.icosa-europe.fr; Rommel consulting https://www.rommel-consulting.be; Groupey https://groupey.fr